Clinical Trial Update: The MIND Study - Microangiopathy IN Diabetes

View source ↗

Summary

The MIND Study (Microangiopathy IN Diabetes) is a clinical trial sponsored by HJN Sverige AB/Neko Health for Type 1 diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: HJN Sverige AB/Neko Health | Conditions: Diabetes Type 1 | Status: RECRUITING